Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Rayonier Advanced Materials (RYAM) Asset Writedowns and Impairment (2021 - 2024)

Rayonier Advanced Materials filings provide 5 years of Asset Writedowns and Impairment readings, the most recent being $25.0 million for Q3 2024.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $25.0 million in Q3 2024 year-over-year; TTM through Dec 2025 was $87.0 million, a N/A change, with the full-year FY2024 number at $25.2 million, down 59.6% from a year prior.
Asset Writedowns and Impairment hit $25.0 million in Q3 2024 for Rayonier Advanced Materials, down from $62.0 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $62.0 million in Q4 2023 to a low of $1.0 million in Q3 2021.
Median Asset Writedowns and Impairment over the past 3 years was $25.0 million (2024), compared with a mean of $29.3 million.